Form 4: Harmony Biosciences CFO Sandip Kapadia Reports Stock Transactions
SEC Form 4 Filing
Sandip Kapadia, CFO of Harmony Biosciences Holdings, Inc., reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On March 29, 2024, Sandip Kapadia, the CFO of Harmony Biosciences Holdings, Inc., reported transactions involving the company's common stock.
- 15,000 shares were acquired through the vesting of restricted stock units.
- 8,013 shares were disposed of to satisfy income tax withholdings at a price of $33.58 per share.
- Following these transactions, Kapadia directly owns 6,987 shares of Harmony Biosciences Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Future Outlook
The remaining 25% of the restricted stock units are scheduled to vest on March 29, 2025.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/29/2021 | Date the restricted stock units were initially granted. |
| 03/29/2023 | 50% of the underlying shares vested. |
| 03/29/2024 | Vesting of 25% of the restricted stock units and subsequent tax withholding. |
| 03/29/2025 | Scheduled vesting of the remaining 25% of the underlying shares. |
| 04/02/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.